logo

Frederick Aronson, MD

Frederick Aronson, MD

Oncology Scarborough, ME

Clinical Professor of Medicine, Tufts University School of Medicine

Office Address

Office Map
  • 100 Campus Drive
    Suite 108
    Scarborough, ME 04074
    Phone: (207) 396-7600
    Fax: (207) 396-7986

Dr. Aronson's Clinical Specialties & Interests

  • Oncology: General Oncology
  • Clinical Interests: Medical Oncology

Dr. Aronson's Faculty Appointments & Work History

  • Clinical ProfessorTufts University, School of Medicine
    Assistant Professor of Medicine (1986-1988); Clinical Professor (2011-Present)
  • Director, Division of Medical OncologyMaine Medical Center
    Portland, ME
    Attending Physician (1993-Present), Director (2006-Present)
  • Consulting Staff PhysicianNew England Rehabilitation Hospital
    Portland, ME
  • Clinical ProfessorTufts University School of Medicine
  • Clinical ProfessorUniversity of Vermont, College of Medicine
  • Attending PhysicianMercy Hospital
    Portland, ME
  • Clinical Associate ProfessorUniversity of Vermont, College of Medicine
  • Assistant Clinical Professor of MedicineUniversity of California, San Francisco, School of Medicine
    San Francisco, CA
  • Assistant Clinical ProfessorUniversity of California, School of Medicine
    San Francisco, CA
  • Director, Biological Response Modifiers ProgramCancer Research Institute, University of California, San Francisco, School of Medicine
    San Francisco, CA
    Research Associate
  • Attending PhysicianHerbert C. Moffitt and Joseph M. Long Hospitals, University of California Medical Center
    San Francisco, CA
  • Assistant PhysicianNew England Medical Center Hospitals
    Boston, MA
  • Assistant Professor of MedicineTufts University School of Medicine
    Boston, MA
  • Staff PhysicianLawrence Memorial Hospital
    Medford, MA

Dr. Aronson's Education & Medical Training

  • Tufts Medical CenterTufts Medical CenterFellowship, Hematology
  • Brown UniversityBrown UniversityResidency, Internal Medicine
  • Yale Univ Sch of MedYale University School of MedicineMedical School
  • Yale University School of MedicineYale University School of MedicineOther Training, MPH, Epidemiology and Biostatistics
  • Johns Hopkins UniversityJohns Hopkins UniversityOther Training, B.A., Molecular Biology

Dr. Aronson's Certifications & Licensure

  • ME State Medical LicenseME State Medical License1993 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineHematology
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Aronson's Awards, Honors, & Recognition

  • Centers for Medicare & Medicaid ServicesMeaningful Use Stage 1 CertificationCenters for Medicare & Medicaid Services, 2012
  • International Society for Biological Therapy of CancerTeam Science Recognition AwardInternational Society for Biological Therapy of Cancer, 2010
  • National Cancer InstituteCo-Principal InvestigatorNational Cancer Institute, 1992-1995
  • Register to See 5 More...

Dr. Aronson's Clinical Trials

Dr. Aronson's Publications & Presentations

PubMed | Citations by Web of Science®

Journal Articles

  • Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma.Mitchell MS, Abrams J, Thompson JA, Kashani-Sabet M, DeConti RC, Hwu WJ, Atkins MB, Whitman E, Ernstoff MS, Haluska FG, Jakowatz JG, Das Gupta TK, Richards JM, Samlows..., J Clin Oncol, 1/1/2007
  • A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma.Ready N, Aronson F, Wanebo H, Kennedy T, Am J Clin Oncol, 1/1/2005
  • Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trials.Atkins MB, Dutcher J, Weiss G, Margolin K, Clark J, Sosman J, Logan T, Aronson F, Mier J, Med Oncol, 1/1/2001
  • Register to See 40 More...

Books/Book Chapters

  • Therapeutic Applications of Interleukin-2.Chapter: Interleukin 2 in combination with other biologic agents.Page 233 - 274
    Sznol M, Thurn A, Aronson FR
    Editors: Atkins MB, Mier JW.Marcel Dekker, Inc., New York, Basel, and Hong Kong
    1993
  • Immunobiology of Renal Cell Carcinoma.Chapter: Interleukin-2 and vinblastine for renal carcinoma.Page 315 - 324
    Aronson FR
    Editors: Klein E, Bukowski RM, Finke J.Marcel Dekker, Inc., New York, Basel, and Hong Kong
    1993
  • Consultation in Internal MedicineChapter: AnemiaPage 445 - 468
    Aronson FR
    Editors: Harrington JT.BC Decker, Inc, Toronto and Philadelphia
    1990
  • Register to See 1 More...

Abstracts/Posters

  • Long-term results with hairy cell leukemia treated with cladribine.Case DC Jr, Ervin TJ, Boyd MA, Aronson FR, Hedlund JA, Proc Am Soc Clin Oncol, 1/1/2005
  • Safety and efficacy of adding rituximab to the ICE regimen (ifosfamide, carboplatin, and etoposide) in previously treated non-Hodgkin's lymphoma.Case DC, Jr, Ebrahim K, Boyd M, Aronson FR, Hayes DM, Proc Am Soc Clin Oncol, 1/1/2004
  • Results of high-dose chemotherapy and autologous stem cell transplantation in patients with acute myeloid leukemia.Ault KA, Case DC Jr, Boyd MA, Ervin TJ, Aronson FR, Ebrahim KS, Hedlund JA, Blood, 1/1/2004
  • Register to See 29 More...

Lectures

  • Probability and Statistics for Oncologists.Oncology Conference, Department of Medicine, Maine Medical Center, Portland, ME. - 6/2/1998
  • Melanoma Update.Advances in Internal Medicine, Department of Medicine, Medical Center of the University of Californi - 6/30/1997
  • HELLP Syndrome and Thrombotic Thrombocytopenic Purpura.Chief's Rounds, Department of Medicine, Maine Medical Center, Portland, ME. - 6/5/1996
  • Register to See 49 More...

Other

  • Progress in Treating Melanoma.Aronson FR
    "Cancer: The Good News," Channel 4 News, San Francisco Bay Area NBC Affiliate Television Station KR - 2/8/1991
  • Legionnaires' Disease: Clinical Features in a Case Control Study.Aronson FR
    1/1/1980

Grant Support

  • Immunology of Melanoma
    Immunology of MelanomaNational Cancer Institute
    1992 - 1995
  • Clinical Trials Of Activated Human Leukocytes
    Clinical Trials Of Activated Human LeukocytesDivision Of Cancer Treatment
    1989 - 1991

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Harvard Pilgrim HMO
  • Health Net HMO - Employer Group
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Aronson's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV